RxDoctor Payments Data

Jason Kolkmeier

Physician Assistant · Shelbyville, INNPI 1093815516

Payments from drug & device makers

$4,549in general payments, 2019–2025

Across 273 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Supernus Pharmaceuticals, Inc.$324
  • Pfizer$234
  • AstraZeneca$213
  • Axsome Therapeutics, Inc.$184
  • Lilly USA, LLC$179
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,549100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,549 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin127$128,929
MounjaroTirzepatide81$89,433
FarxigaDapagliflozin Propanediol98$87,744
RybelsusSemaglutide52$84,749
OzempicSemaglutide51$65,526
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$55,388
EliquisApixaban48$45,251
Repatha SureclickEvolocumab36$37,575
LinzessLinaclotide29$19,139
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$15,776
XareltoRivaroxaban21$15,053
TradjentaLinagliptin19$13,043
Aripiprazole27$11,619
TrintellixVortioxetine Hydrobromide15$10,496
VascepaIcosapent Ethyl23$8,868

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$139$150,275103 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$167$147,671158 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$213$107,686136 claims
Lilly USA, LLCMounjaro$179$89,43381 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta, Arexvy$56$83,094140 claims
PfizerEliquis$234$45,25148 claims
AbbVieLinzess, Synthroid$1,295$20,73040 claims
Johnson & JohnsonXarelto$26$15,05321 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$39$10,49615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Shelbyville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →